The emerging class of GLP-1 agonist medication and GIP co-agonist medications, such as tirzepatide, semaglutide, and the relatively introduced retatrutide, represent significant improvements in the control. https://retatrutide979355.ka-blogs.com/97338683/retatrutide-the-comparative-review